Transcranial focused ultrasound for targeted drug delivery

Meaghan O’Reilly is a Senior Scientist in Physical Sciences at Sunnybrook Research Institute in Toronto, Canada, an Associate Professor of Medical Biophysics at the University of Toronto, and the Tier 2 Canada Research Chair in Biomedical Ultrasound. Dr. O’Reilly’s research interests include ultrasound therapy applications in the central nervous system, with a focus on delivery, monitoring and control of microbubble-mediated therapies in the brain and spinal cord.

Learning Objectives:

1. To understand the mechanisms by which ultrasound can permeabilize cerebral vasculature

2. To learn about the technological challenges for transcranial ultrasound delivery

3. To review the current clinical status 

Link to recording